Market Overview

Goldman Believes TherapeuticsMD Is 'Revitalizing Women's Health,' Initiates With Buy

Share:
Related
40 Stocks Moving In Tuesday's Pre-Market Session
40 Biggest Movers From Yesterday
Related XBI
ASH 2017 Highlights: Gilead, Novartis, Juno, Bluebird Bio And More
Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates
Chirality, From Chemical Supply Houses To Life As We Know It (Seeking Alpha)

TherapeuticsMD Inc (NYSE: TXMD), a small-cap women's healthcare product company might be “revitalizing women’s health.” At least, this is what analysts at Goldman Sachs believe. The firm initiated coverage of the stock with a Buy rating and 12-month price target of $10.00, which implied an upside of more than 50 percent from Friday’s closing price.

While the SPDR S&P Biotech (ETF) (NYSE: XBI) has lost about 30 percent since December 29, TherapeuticsMD has tumbled about 40 percent, even though no significant news transcended. The experts think the company “has been unfairly classified as a biopharma whereas it faces a more consumer-like market opportunity.”

Related Link: Jefferies' Best Biotech Ideas For 2016 (And Beyond)

They see the stock returning to prior levels on the back of:

1) An emphasis on well developed markets with elevated unmet needs

2) A product portfolio centered on women’s health, which is a core competency

3) “A late stage differentiated pipeline.”

These elements support the analysts’ optimistic outlook for EPS growth, which suggests TherapeuticsMD is both under-valued and under-appreciated.

Shares of TherapeuticsMD were trading up more than 10 percent on Monday afternoon.

Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.

Latest Ratings for TXMD

DateFirmActionFromTo
Sep 2017Morgan StanleyInitiates Coverage OnEqual-Weight
Jul 2017Deutsche BankInitiates Coverage OnBuy
Jul 2017OppenheimerUpgradesPerformOutperform

View More Analyst Ratings for TXMD
View the Latest Analyst Ratings

Posted-In: Analyst Color Biotech Long Ideas Price Target Initiation Analyst Ratings Trading Ideas General

 

Related Articles (XBI + TXMD)

View Comments and Join the Discussion!